Cerus Stock (NASDAQ: CERS) stock price, news, charts, stock research, profile.
Open | $1.640 |
Close | $1.700 |
Volume / Avg. | 951.750K / 1.602M |
Day Range | 1.610 - 1.715 |
52 Wk Range | 1.205 - 3.080 |
Market Cap | $308.181M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 42 |
Short Interest | 3.34% |
Days to Cover | 1.58 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cerus (NASDAQ: CERS) through any online brokerage.
Other companies in Cerus’s space includes: Solventum (NYSE:SOLV), RxSight (NASDAQ:RXST), TELA Bio (NASDAQ:TELA), Embecta (NASDAQ:EMBC) and Align Tech (NASDAQ:ALGN).
The latest price target for Cerus (NASDAQ: CERS) was reported by Craig-Hallum on Friday, April 12, 2024. The analyst firm set a price target for 5.00 expecting CERS to rise to within 12 months (a possible 194.12% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Cerus (NASDAQ: CERS) is $1.7 last updated April 25, 2024 at 5:29 PM EDT.
There are no upcoming dividends for Cerus.
Cerus’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Cerus.
Cerus is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.